| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/23/2008 | US7427397 Vitamin B12 supplement comprising Propionibacterium jensenii 702 together with a delivery agent; tuberculosis |
| 09/23/2008 | US7427394 Delivering labile agents; buffering effect; transfecting nucleic acids; nontoxic |
| 09/23/2008 | CA2333323C Method and compositions for treatment of cancers |
| 09/23/2008 | CA2186004C Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules |
| 09/23/2008 | CA2163256C Adenoviral vectors of animal origin and use thereof in gene therapy |
| 09/23/2008 | CA2143125C Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein |
| 09/18/2008 | WO2008112917A2 Peptidyl fluoromethylketones as inhibitors of viral replication |
| 09/18/2008 | WO2008112344A2 Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins |
| 09/18/2008 | WO2008112325A2 Treatment of autoimmune disorders |
| 09/18/2008 | WO2008112290A2 Use of ephb4 as a diagnostic marker and a therapeutic target for ovarian cancer |
| 09/18/2008 | WO2008112192A2 Epha3 antibodies for the treatment of solid tumors |
| 09/18/2008 | WO2008112129A2 Treatment of carcinomas with a combination of egf-pathway and telomerase inhibitors |
| 09/18/2008 | WO2008112125A1 Papillomavirus vaccine compositions |
| 09/18/2008 | WO2008112007A1 Immunoreactive glycoprotein gp19 of ehrlichia canis |
| 09/18/2008 | WO2008112003A2 Targeted binding agents directed to pdgfr-alpha and uses thereof |
| 09/18/2008 | WO2008111996A2 Muc1-ikb kinase complexes and their activities |
| 09/18/2008 | WO2008111990A1 Rare cell analysis using sample splitting and dna tags |
| 09/18/2008 | WO2008111943A2 Secreted campylobacter flagella coregulated proteins as immunogens |
| 09/18/2008 | WO2008111634A1 Biomarker specific to brain/nerve or specific to neuronal differentiation |
| 09/18/2008 | WO2008111597A1 Remedy for chemotherapy-resistant cancer containing hla class i-recognizing antibody as the active ingredient and use of the same |
| 09/18/2008 | WO2008111532A1 Lyophilized preparation comprising influenza vaccine, and method for preparation thereof |
| 09/18/2008 | WO2008111520A1 Gene related to life extension and use thereof |
| 09/18/2008 | WO2008111441A1 Pharmaceutical composition |
| 09/18/2008 | WO2008110912A1 Fertility regulation in horses |
| 09/18/2008 | WO2008110885A2 Methods of treating ophthalmic diseases |
| 09/18/2008 | WO2008110771A2 Composition comprising an il-8 blocking agent and/or a trail blocking agent for use in the treatment of liver disease and hepatic flares |
| 09/18/2008 | WO2008110695A1 Novel multimeric molecules, method for preparing same and use thereof in the preparation of drugs |
| 09/18/2008 | WO2008110627A1 Novel vaccine composition for the treatment of respiratory infectious diseases |
| 09/18/2008 | WO2008110379A2 Monoclonal antibodies for treatment of cancer |
| 09/18/2008 | WO2008110373A1 Method of providing human tumor-specific antibodies |
| 09/18/2008 | WO2008110372A1 Monoclonal human tumor-specific antibody |
| 09/18/2008 | WO2008110056A1 A vaccine for porcine reproductive and respiratory syndrome, a preparion method and use thereof |
| 09/18/2008 | WO2008109997A1 Procaspase 8-mediated disease targeting |
| 09/18/2008 | WO2008109992A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 09/18/2008 | WO2008109958A1 Methods for evaluation of oral vaccines |
| 09/18/2008 | WO2008109957A1 Method for determining suitability of treatment for asthma or chronic airways disease |
| 09/18/2008 | WO2008109956A1 Treatment or prophylaxis of asthma |
| 09/18/2008 | WO2008091601A3 Methods and compositions for enhancing growth of fish and shellfish |
| 09/18/2008 | WO2008091375A9 Attenuated salmonella as a delivery system for sirna-based tumor therapy |
| 09/18/2008 | WO2008088738A3 Novel methods for modulating inflammatory and/or immune responses |
| 09/18/2008 | WO2008085406A3 Modified live (jmso strain) haemophilus parasuis vaccine |
| 09/18/2008 | WO2008076379A3 Human antibodies to human delta like ligand 4 |
| 09/18/2008 | WO2008076255A3 Canine thymic stromal lymphopoietin protein and uses thereof |
| 09/18/2008 | WO2008070721A3 High protein concentration formulations containing mannitol |
| 09/18/2008 | WO2008069889A9 Methods of treating hemolytic anemia |
| 09/18/2008 | WO2008057235A9 Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes |
| 09/18/2008 | WO2008057158A9 Novel neutralizing immunogen (nimiv) of rhinovirus and its use for vaccine applications |
| 09/18/2008 | WO2008054523A9 Nanostructures, methods of synthesizing thereof, and methods of use thereof |
| 09/18/2008 | WO2008045437A3 Chimeric t-cell receptors and t-cells targeting egfrviii on tumors |
| 09/18/2008 | WO2008039206A3 Fusion proteins for inhibition and dissolution of coagulation |
| 09/18/2008 | WO2008032073A3 Novel nematode protein and its use in producing anthelminthic agents and vaccines |
| 09/18/2008 | WO2008027560A3 Holin-enhanced vaccines and reagents, and methods of use thereof |
| 09/18/2008 | WO2008019018A3 Bioactive molecular matrix and methods of use in the treatment of disease |
| 09/18/2008 | WO2007143701A3 Monoclonal antibodies that potently neutralize hepatitis c virus (hcv) of diverse genotypes |
| 09/18/2008 | WO2007100543A8 Extracellular matrix to treat malignancy in mammals |
| 09/18/2008 | US20080227959 Immunogenic compounds for producing antibodies to efavirenz; monoclonal antibodies; immunoassays for selectively determining efavirenz levels in plasma; treatment failure and central nervous system side effects due to low and high plasma levels, respectively |
| 09/18/2008 | US20080227957 Reducing Immunogenicities of Immunoglobulins by Framework-Patching |
| 09/18/2008 | US20080227751 Method and agent for the prevention, inhibition and treatment of sepsis |
| 09/18/2008 | US20080227739 Isolated polypeptide comprising amino acid sequence encoded by polynucleotide; physiologically acceptable carriers and immunostimulants |
| 09/18/2008 | US20080227719 administering to a patient an effective dosage of a polypeptide comprising an N-terminal segment of A beta , the segment beginning at residue 1-3 of A beta and ending at residues 7-11 of A beta to treat disease associated with amyloid deposit of A beta in the brain Alzheimer's disease, Down's syndrome |
| 09/18/2008 | US20080227718 administering to a patient an effective dosage of a polypeptide comprising an N-terminal segment of A beta , the segment beginning at residue 1-3 of A beta and ending at residues 7-11 of A beta to treat disease associated with amyloid deposit of A beta in the brain Alzheimer's disease, Down's syndrome |
| 09/18/2008 | US20080227706 Polypeptides and polynucleotides; genetic engineering; medical diagnosis; treatment of infection causes sepsis, meningitis, pneumonia, cellulitis, osteomyelitis, septic arthritis, endocarditis or epiglottis; bacterial protein antigen vaccine |
| 09/18/2008 | US20080227198 Using anti-CD80 antibody to induce lymphocyte response which targets B cell malignancies |
| 09/18/2008 | US20080227156 Nucleotide sequences coding myostatin epitopes for use in treatment and prevention of diabetic disorders; immunotherapy |
| 09/18/2008 | US20080227146 Immortalized Avian Cell Lines For Virus Production |
| 09/18/2008 | US20080227121 Using collagen XIII peptide as evaluative tool in identifying modulators monocyte efflux into interstitial space; treating chronic inflammatory disorders |
| 09/18/2008 | US20080227106 Compositions and methods for the diagnosis and treatment of tumor |
| 09/18/2008 | US20080227082 Method of identifying a mhc class i restricted t cell response |
| 09/18/2008 | US20080226766 Determining susceptibility to periodontitis in a Shih Tzu dog, Yorkshire Terrier dog or a dog of a breed that is genetically related; by use of computer program |
| 09/18/2008 | US20080226729 Formed by atomizing liquid formulation comprising immunogen (selected from Botulinum neurotoxin, Bacillus antracis antigen, Staphylococcal enterotoxin, Yersinia pestis antigen) adsorbed onto aluminum adjuvant, freezing, then drying |
| 09/18/2008 | US20080226725 New and Advantageous Hydrogel Composition |
| 09/18/2008 | US20080226722 Gel Composition Comprising Charged Polymers |
| 09/18/2008 | US20080226709 Binding allergen or antigen to surface of phosphatide membrane; immunology response; side effect reduction |
| 09/18/2008 | US20080226687 Drug delivery and method having coated microprojections incorporating vasoconstrictors |
| 09/18/2008 | US20080226681 Highly Active Glycoproteins-Process Conditions and an Efficient Method for their Production |
| 09/18/2008 | US20080226680 Applying flavored therapeutic to animal muzzle and allowing licking action to deliver medicine to nasal and/or oral mucosa |
| 09/18/2008 | US20080226679 Novel surface exposed proteins from chlamydia pneumoniae |
| 09/18/2008 | US20080226678 Generating lymphocytes immune response; vector gene expression ; induction lymphocyte response against antigen using adenovirus vector; antiulcer agents; inflammatory bowel disorders; autoimmune diseases; anticancer agenst |
| 09/18/2008 | US20080226677 Recombinant virus vector for gene transfer into lymphoid cells |
| 09/18/2008 | US20080226676 Multivalent avian influenza vaccines and methods |
| 09/18/2008 | US20080226675 Supplying genes to human cells; gene expression blocks; mutant lentivirus vectors; prevention, therapy aids |
| 09/18/2008 | US20080226674 Anticancer drugs encapsulated in and mixed with envelop protein virus vector; intensify immunology response in animals |
| 09/18/2008 | US20080226673 Subunit vaccine against respiratory syncytial virus infection |
| 09/18/2008 | US20080226672 Adjuvant Systems and Vaccines |
| 09/18/2008 | US20080226671 Deactivation or attenuation Mycoplasma vaccine for cattle; side effect reduction; respiratory system disorders ; mammary disorders; joint, eye, ear infections |
| 09/18/2008 | US20080226670 Prevent disease caused by Bordetella; distemper; hepatitis; adenovirus; enteritis; coronavirus; parvirus;leptospira |
| 09/18/2008 | US20080226669 Protein which expresses open reading frame of circoviruses |
| 09/18/2008 | US20080226668 Immunomodulation by a therapeutic medication intended for treatment of diabetes and prevention of autoimmune diabetes |
| 09/18/2008 | US20080226667 Toll-like receptor modulator for use in prevention and treatment of neurodegenerative disorders |
| 09/18/2008 | US20080226666 Immunogenic polypeptide for protecting pigs against viral infection or postweaning multisystemic wasting syndrome |
| 09/18/2008 | US20080226665 EphA2 T-cell epitopes and uses therefor |
| 09/18/2008 | US20080226664 Colon cancer antigen panel |
| 09/18/2008 | US20080226663 Pine Cone Extracts and Uses Thereof |
| 09/18/2008 | US20080226662 Nucleotide sequences coding mammalian immune system modulator (B7-DC) for use in treatment and prevention of viral infcetion a nd cell proliferative disorders; immunotherapy |
| 09/18/2008 | US20080226661 Using immunoaffinity recognition to identify phage clones expressing mycoplasma peptides; developing vaccines for prevention and treatment of contagious bovine pleuropneumonia |
| 09/18/2008 | US20080226660 Nucleotide sequences coding human papilloma viral like particles (Hpv 58 L1) for use in designing vaccine for prevention virus associated cell proliferative disorders |
| 09/18/2008 | US20080226659 Methods of treatment using anti-erbb antibody-maytansinoid conjugates |
| 09/18/2008 | US20080226658 Lysosomal conjugate for use in treatment of fabry, gaucher or niemann-pick diseases |
| 09/18/2008 | US20080226657 Monomethylvaline compounds capable of conjugation to ligands |
| 09/18/2008 | US20080226656 RG1 antibodies and uses thereof |